Bhattacharya Siddhartha, Kumar S Saravana, Swamy Parimala Devi Kumara, Palanivelu C, Raj P Praveen
GEM Hospital and Research Centre, Coimbatore, Tamil Nadu, India.
J Minim Access Surg. 2018 Oct-Dec;14(4):285-290. doi: 10.4103/jmas.JMAS_151_17.
Obesity is a risk factor for deep vein thrombosis (DVT) and venous thromboembolism (VTE). VTE is the most common cause of mortality in patients undergoing bariatric surgery. There is considerable variation in practice regarding methods, dosages and duration of prophylaxis in this patient population. Most of the literature is based on Western patients and specific guidelines for Asians do not exist.
We conducted a web-based survey amongst 11 surgeons from high-volume centres in Asia regarding their DVT prophylaxis measures in patients undergoing bariatric surgery. We collected and analysed the data.
The reported incidence of DVT and VTE ranged from 0% to 0.2%. Most surgeons (63.64%) preferred to use both mechanical and chemoprophylaxis with low-molecular-weight heparin being the most preferred form of chemoprophylaxis (81.82%). There was an equal distribution of weight-based, body mass index-based and fixed-dose regimens. Duration of chemoprophylaxis ranged from 3-5 days after surgery to 2 weeks after surgery. For high-risk patients, 60% surgeons preferred to start chemoprophylaxis at least 1 week before surgery. Routine use of inferior vena cava filters in high-risk patients was not preferred with some surgeons adopting a selective use (36.36%).
The purpose of this survey was to understand the trends in DVT prophylaxis amongst different high-volume bariatric centres in Asia and to relate the same with the existing literature on the different steps in prophylaxis. There is, however, a need for consensus guidelines for DVT prophylaxis in Asian obese.
肥胖是深静脉血栓形成(DVT)和静脉血栓栓塞症(VTE)的危险因素。VTE是肥胖症手术患者最常见的死亡原因。在这一患者群体中,关于预防方法、剂量和持续时间的实际操作存在很大差异。大多数文献基于西方患者,不存在针对亚洲人的具体指南。
我们对来自亚洲高容量中心的11名外科医生进行了一项关于肥胖症手术患者DVT预防措施的网络调查。我们收集并分析了数据。
报告的DVT和VTE发生率在0%至0.2%之间。大多数外科医生(63.64%)倾向于同时使用机械预防和化学预防,低分子量肝素是最常用的化学预防形式(81.82%)。基于体重、基于体重指数和固定剂量方案的分布相同。化学预防的持续时间从术后3 - 5天到术后2周不等。对于高危患者,60%的外科医生倾向于在手术前至少1周开始化学预防。高危患者常规使用下腔静脉滤器不受青睐,一些外科医生采用选择性使用(36.36%)。
本次调查的目的是了解亚洲不同高容量肥胖症中心DVT预防的趋势,并将其与现有文献中预防的不同步骤相关联。然而,亚洲肥胖患者的DVT预防需要达成共识指南。